Article Versions Notes

Crespo B, Illera JC, Silvan G, Lopez-Plaza P, Herrera de la Muela M, de la Puente Yague M, Diaz del Arco C, de Andrés PJ, Illera MJ, Caceres S. Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines. International Journal of Molecular Sciences. 2024; 25(14):7923. https://doi.org/10.3390/ijms25147923

Crespo, Belen, Juan Carlos Illera, Gema Silvan, Paula Lopez-Plaza, María Herrera de la Muela, Miriam de la Puente Yague, Cristina Diaz del Arco, Paloma Jimena de Andrés, Maria Jose Illera, and Sara Caceres. 2024. "Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines" International Journal of Molecular Sciences 25, no. 14: 7923. https://doi.org/10.3390/ijms25147923

Crespo, B., Illera, J. C., Silvan, G., Lopez-Plaza, P., Herrera de la Muela, M., de la Puente Yague, M., Diaz del Arco, C., de Andrés, P. J., Illera, M. J., & Caceres, S. (2024). Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines. International Journal of Molecular Sciences, 25(14), 7923. https://doi.org/10.3390/ijms25147923